Bank of New Hampshire Cuts Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Bank of New Hampshire trimmed its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,881 shares of the company’s stock after selling 248 shares during the period. Bank of New Hampshire’s holdings in Cardinal Health were worth $2,508,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Cornerstone Wealth Management LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth approximately $209,000. Nordea Investment Management AB raised its holdings in Cardinal Health by 50.5% during the fourth quarter. Nordea Investment Management AB now owns 184,537 shares of the company’s stock worth $18,649,000 after purchasing an additional 61,933 shares in the last quarter. Vest Financial LLC raised its holdings in Cardinal Health by 15.9% during the fourth quarter. Vest Financial LLC now owns 282,440 shares of the company’s stock worth $28,470,000 after purchasing an additional 38,769 shares in the last quarter. Bellwether Advisors LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $6,290,000. Finally, DekaBank Deutsche Girozentrale grew its position in Cardinal Health by 30.1% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 547,525 shares of the company’s stock valued at $54,618,000 after buying an additional 126,668 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.3 %

Cardinal Health stock traded down $0.33 during trading on Friday, hitting $103.48. The stock had a trading volume of 494,693 shares, compared to its average volume of 2,244,121. The stock has a market cap of $25.17 billion, a price-to-earnings ratio of 40.87, a price-to-earnings-growth ratio of 1.00 and a beta of 0.68. The stock’s 50 day moving average is $109.54 and its two-hundred day moving average is $104.58. Cardinal Health, Inc. has a 1 year low of $77.56 and a 1 year high of $116.04.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business had revenue of $57.45 billion for the quarter, compared to analysts’ expectations of $57.02 billion. During the same quarter in the prior year, the firm earned $1.32 earnings per share. The firm’s revenue was up 11.6% on a year-over-year basis. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. Cardinal Health’s payout ratio is 78.74%.

Wall Street Analyst Weigh In

CAH has been the topic of several recent research reports. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Barclays started coverage on Cardinal Health in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price target for the company. SVB Leerink initiated coverage on Cardinal Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $125.00 price objective on the stock. Finally, Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $103.07.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.